Nogalamycin (Synonyms: NSC 70845, U 15167) |
| Catalog No.GC44438 |
CCG-273220 est un inhibiteur covalent de la kinase 5 (GRK5) du récepteur couplé aux protéines G (GPCR) avec une valeur IC50 de 220 nM. CCG-273220 est hautement sélectif pour GRK5 par rapport À GRK2 (IC50 = 350 μM) en liant Cys474, un résidu spécifique de la sous-famille GRK5, en tant que poignée covalente.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1404-15-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Nogalamycin is an anthracycline originally isolated from S. nogalater and a DNA-intercalating agent. It inhibits the DNA-unwinding and ATPase activities of P. falciparum DNA helicase 60 (IC50s = 2 and 0.5 μM, respectively) and the DNA cleavage activity of vaccinia virus topoisomerase (IC50 = 0.7 μM). Nogalamycin also inhibits the growth of MCF-7 and MDA-MB-231 human breast cancer cells (IC50s = 0.242 and 0.37 μM, respectively).
Average Rating: 5 (Based on Reviews and 1 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *